NT_1170x120_1-11-18

Yaz

Mylan adds to growing women’s healthcare portfolio

Mylan adds to growing women’s healthcare portfolio

HERTFORDSHIRE, England and PITTSBURGH — Global pharmaceutical company Mylan N.V. announced the U.S. launch of Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg, a generic version of Bayer’s Yaz tablets. Mylan Pharmaceuticals received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which